<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Patients with <z:e sem="disease" ids="C1261469" disease_type="Disease or Syndrome" abbrv="ESRD">end-stage kidney disease</z:e> (ESKD) and patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> experience higher mortality rates than the general population </plain></SENT>
<SENT sid="1" pm="."><plain>Whether ESKD imparts the same excess in mortality risk for those with <z:mp ids='MP_0002055'>diabetes</z:mp> as it does for those without <z:mp ids='MP_0002055'>diabetes</z:mp> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Included in the study were <z:hpo ids='HP_0000001'>all</z:hpo> white patients aged &gt; or =25 years with incident ESKD and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 4,141) or with incident ESKD but without <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 13,289) in Australia from 1991 to 2005, and <z:hpo ids='HP_0000001'>all</z:hpo> the individuals aged &gt; or =25 years without ESKD and with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 909) or without ESKD without <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 10,302) enrolled in the AusDiab Study--a nationwide Australian representative cohort--from 1999 to 2005 </plain></SENT>
<SENT sid="3" pm="."><plain>Excess mortality was analysed in patients with ESKD by <z:mp ids='MP_0002055'>diabetes</z:mp> status, using age-, sex- and <z:mp ids='MP_0002055'>diabetes</z:mp>-status-specific standardised mortality ratios (SMRs) in the first 8 years after first renal replacement therapy among ANZDATA patients relative to AusDiab participants </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The SMRs in patients with ESKD were, in non-diabetic patients and in those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, respectively: 14.2 (95% CI 13.9-14.6) and 10.8 (95% CI 10.4-11.2) (p &lt; 0.01); in people aged &lt;60 years, 28.7 (95% CI 27.2-30.4) and 18.6 (95% CI 17.1-20.4) (p &lt; 0.01); in people aged &gt; or =60 years, 12.5 (95% CI 12.1-12.9) vs 9.7 (95% CI 9.3-10.1) (p &lt; 0.01); in men, 11.0 (95% CI 10.7-11.4) vs 8.9 (95% CI 8.4-9.3) (p &lt; 0.01); and in women, 23.4 (95% CI 22.5-24.3) vs 16.2 (95% CI 15.2-17.3) (p &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS/INTERPRETATION: ESKD was associated with a greater relative increase in mortality in the non-diabetic study populations than in the type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> population </plain></SENT>
<SENT sid="6" pm="."><plain>Excess mortality was greater among younger people and women </plain></SENT>
</text></document>